Human leukocyte antigen class I supertypes and HIV-1 control in African Americans

Journal of Virology

Volumn 84, Issue 5, 2010, Pages 2610-2617

  Lazaryan, Aleksandr ^a   Song, Wei ^a   Lobashevsky, Elena ^a   Tang, Jianming ^a   Shrestha, Sadeep ^a   Zhang, Kui ^a   Gardner, Lytt I ^b   McNicholl, Janet M ^b   Wilson, Craig M ^a   Klein, Robert S ^c   Rompalo, Anne ^d   Mayer, Kenneth ^e   Sobel, Jack ^f   Kaslow, Richard A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e BROWN UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA B44 ANTIGEN; HLA B58 ANTIGEN; HLA B62 ANTIGEN; HLA B7 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS LOAD;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ALLELES; CHILD; FEMALE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; MIDDLE AGED; ODDS RATIO; VIRAL LOAD; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77649207758     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01962-09     Document Type: Article

References (45)

1. Allison, P. D. 2000. Multiple imputation for missing data: a cautionary tale. Sociol. Methods Res. 28:301-309.
2. Brander, C. 2004. HLA and HIV: implications for HIV vaccine design. ASHI Q. 2004:58-59.
3. Brumme, C., C. Chui, C. Woods, B. Wynhoven, R. Hogg, J. Montaner, P. Harrigan, and Z. Brumme. 2006. Specific HLA-B alleles known to influence untreated HIV-1 disease progression do not appear to affect response to highly active antiretroviral therapy. Can. J. Infect. Dis. Med. Microbiol. 17(Suppl. A):114.
4. Brumme, Z. L., C. J. Brumme, C. Chui, T. Mo, B. Wynhoven, C. K. Woods, B. M. Henrick, R. S. Hogg, J. S. Montaner, and P. R. Harrigan. 2007. Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy. J. Infect. Dis. 195:1694-1704.
5. Burnham, K. P., and D. R. Anderson. 2002. Model selection and multimodel inference: a practical-theoretic approach, 2nd ed. Springer-Verlag, New York, NY.
6. Dorak, M. T., J. Tang, S. Tang, A. Penman-Aguilar, R. A. Coutinho, J. J. Goedert, R. Detels, and R. A. Kaslow. 2003. Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white men. J. Infect. Dis. 188:856-863.
7. Doytchinova, I. A., P. Guan, and D. R. Flower. 2004. Identifying human MHC supertypes using bioinformatic methods. J. Immunol. 172:4314-4323.
8. Emu, B., E. Sinclair, H. Hatano, A. Ferre, B. Shacklett, J. N. Martin, J. M. McCune, and S. G. Deeks. 2008. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J. Virol. 82:5398-5407.
9. Feeney, M. E., Y. Tang, K. A. Roosevelt, A. J. Leslie, K. McIntosh, N. Karthas, B. D. Walker, and P. J. Goulder. 2004. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 78:8927-8930.
10. Flores-Villanueva, P. O., E. J. Yunis, J. C. Delgado, E. Vittinghoff, S. Buchbinder, J. Y. Leung, A. M. Uglialoro, O. P. Clavijo, E. S. Rosenberg, S. A. Kalams, J. D. Braun, S. L. Boswell, B. D. Walker, and A. E. Goldfeld. 2001. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA 98:5140-5145.
11. Frahm, N., S. Adams, P. Kiepiela, C. H. Linde, H. S. Hewitt, M. Lichterfeld, K. Sango, N. V. Brown, E. Pae, A. G. Wurcel, M. Altfeld, M. E. Feeney, T. M. Allen, T. Roach, M. A. St John, E. S. Daar, E. Rosenberg, B. Korber, F. Marincola, B. D. Walker, P. J. Goulder, and C. Brander. 2005. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J. Virol. 79:10218-10225.
12. Gao, X., G. W. Nelson, P. Karacki, M. P. Martin, J. Phair, R. Kaslow, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, S. J. O'Brien, and M. Carrington. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344:1668-1675.
13. Geczy, A. F., H. Kuipers, M. Coolen, L. J. Ashton, C. Kennedy, G. Ng, R. Dodd, R. Wallace, T. Le, C. H. Raynes-Greenow, W. B. Dyer, J. C. Learmont, and J. S. Sullivan. 2000. HLA and other host factors in transfusion-acquired HIV-1 infection. Hum. Immunol. 61:172-176.
14. Glynn, M. K., and P. Rhodes. 2005. Estimated HIV prevalence in the United States at the end of 2003. 2005 Natl. HIV Prev. Conf., Atlanta, GA.
15. Goulder, P. J., C. Brander, K. Annamalai, N. Mngqundaniso, U. Govender, Y. Tang, S. He, K. E. Hartman, C. A. O'Callaghan, G. S. Ogg, M. A. Altfeld, E. S. Rosenberg, H. Cao, S. A. Kalams, M. Hammond, M. Bunce, S. I. Pelton, S. A. Burchett, K. McIntosh, H. M. Coovadia, and B. D. Walker. 2000. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J. Virol. 74:5679-5690.
16. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, A. J. McMichael, and S. Rowland-Jones. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
17. Hall, H. I., R. Song, P. Rhodes, J. Prejean, Q. An, L. M. Lee, J. Karon, R. Brookmeyer, E. H. Kaplan, M. T. McKenna, and R. S. Janssen. 2008. Estimation of HIV incidence in the United States. JAMA 300:520-529.
18. Harrer, E. G., S. Bergmann, K. Eismann, M. Rittmaier, A. Goldwich, S. M. Muller, B. M. Spriewald, and T. Harrer. 2005. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients. AIDS 19:734-735.
19. Hendel, H., S. Caillat-Zucman, H. Lebuanec, M. Carrington, S. O'Brien, J. M. Andrieu, F. Schachter, D. Zagury, J. Rappaport, C. Winkler, G. W. Nelson, and J. F. Zagury. 1999. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J. Immunol. 162: 6942-694.
20. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-411.
21. Keet, I. P., J. Tang, M. R. Klein, S. LeBlanc, C. Enger, C. Rivers, R. J. Apple, D. Mann, J. J. Goedert, F. Miedema, and R. A. Kaslow. 1999. Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J. Infect. Dis. 180:299-309.
22. Kiepiela, P., A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale, S. Chetty, P. Rathnavalu, C. Moore, K. J. Pfafferott, L. Hilton, P. Zimbwa, S. Moore, T. Allen, C. Brander, M. M. Addo, M. Altfeld, I. James, S. Mallal, M. Bunce, L. D. Barber, J. Szinger, C. Day, P. Klenerman, J. Mullins, B. Korber, H. M. Coovadia, B. D. Walker, and P. J. Goulder. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775.
23. Lazaryan, A., E. Lobashevsky, J. Mulenga, E. Karita, S. Allen, J. Tang, and R. A. Kaslow. 2006. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J. Virol. 80:6056-6060.
24. Leslie, A., D. A. Price, P. Mkhize, K. Bishop, A. Rathod, C. Day, H. Crawford, I. Honeyborne, T. E. Asher, G. Luzzi, A. Edwards, C. M. Rousseau, J. I. Mullins, G. Tudor-Williams, V. Novelli, C. Brander, D. C. Douek, P. Kiepiela, B. D. Walker, and P. J. Goulder. 2006. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J. Immunol. 177:4699-4708.
25. Lund, O., M. Nielsen, C. Kesmir, A. G. Petersen, C. Lundegaard, P. Worning, C. Sylvester-Hvid, K. Lamberth, G. Roder, S. Justesen, S. Buus, and S. Brunak. 2004. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55:797-810.
26. Magierowska, M., I. Theodorou, P. Debre, F. Sanson, B. Autran, Y. Riviere, D. Charron, and D. Costagliola. 1999. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 93: 936-941.
27. Ngumbela, K. C., C. L. Day, Z. Mncube, K. Nair, D. Ramduth, C. Thobakgale, E. Moodley, S. Reddy, C. de Pierres, N. Mkhwanazi, K. Bishop, M. van der Stok, N. Ismail, I. Honeyborne, H. Crawford, D. G. Kavanagh, C. Rousseau, D. Nickle, J. Mullins, D. Heckerman, B. Korber, H. Coovadia, P. Kiepiela, P. J. Goulder, and B. D. Walker. 2008. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res. Hum. Retrovir. 24:72-82.
28. Novitsky, V., P. Gilbert, T. Peter, M. F. McLane, S. Gaolekwe, N. Rybak, I. Thior, T. Ndung'u, R. Marlink, T. H. Lee, and M. Essex. 2003. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J. Virol. 77:882-890.
29. Peter, J. B., and J. S. Sevall. 2004. Molecular-based methods for quantifying HIV viral load. AIDS Patient Care STDS 18:75-79.
30. Qing, M., T. Li, Y. Han, Z. Qiu, and Y. Jiao. 2006. Accelerating effect of human leukocyte antigen-Bw6 homozygosity on disease progression in Chinese HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 41:137-139.
31. Rogers, A. S., D. K. Futterman, A. B. Moscicki, C. M. Wilson, J. Ellenberg, and S. H. Vermund. 1998. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. J. Adolesc. Health 22:300-311.
32. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, et al. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
33. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K. Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860-861.
34. Scherer, A., J. Frater, A. Oxenius, J. Agudelo, D. A. Price, H. F. Gunthard, M. Barnardo, L. Perrin, B. Hirschel, R. E. Phillips, and A. R. McLean. 2004. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. Proc. Natl. Acad. Sci. USA 101:12266-12270.
35. Schmitz, J. E., M. J. Kuroda, S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, J. Ghrayeb, M. A. Forman, D. C. Montefiori, E. P. Rieber, N. L. Letvin, and K. A. Reimann. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860.
36. Schunk, D. 2008. A Markov chain Monte Carlo algorithm for multiple imputation in large surveys. Adv. Stat. Anal. 92:101-114.
37. Sette, A., and J. Sidney. 1998. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10:478-482.
38. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212.
39. Sidney, J., B. Peters, N. Frahm, C. Brander, and A. Sette. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9:1.
40. Singer, J. D. 1998. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J. Educ. Behav. Stat. 24:323-355.
41. Smith, D. K., D. L. Warren, D. Vlahov, P. Schuman, M. D. Stein, B. L. Greenberg, and S. D. Holmberg. 1997. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am. J. Epidemiol. 146:459-469.
42. Tang, J., S. Tang, E. Lobashevsky, A. D. Myracle, U. Fideli, G. Aldrovandi, S. Allen, R. Musonda, and R. A. Kaslow. 2002. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 76:8276-8284.
43. Tang, J., C. M. Wilson, S. Meleth, A. Myracle, E. Lobashevsky, M. J. Mulligan, S. D. Douglas, B. Korber, S. H. Vermund, and R. A. Kaslow. 2002. Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents. AIDS 16:2275-2284.
44. Trachtenberg, E., B. Korber, C. Sollars, T. B. Kepler, P. T. Hraber, E. Hayes, R. Funkhouser, M. Fugate, J. Theiler, Y. S. Hsu, K. Kunstman, S. Wu, J. Phair, H. Erlich, and S. Wolinsky. 2003. Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9:928-935.
45. Wilson, C. M., J. Houser, C. Partlow, B. J. Rudy, D. C. Futterman, and L. B. Friedman. 2001. The REACH (Reaching for Excellence in Adolescent Care and Health) project: study design, methods, and population profile. J. Adolesc. Health 29:8-18.